Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Errol Babacan

Decrease of Atazanavir and Lopinavir Plasma Concentrations in a Boosted Double Human Immunodeficiency Virus Protease Inhibitor Salvage Regimen

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2008

English

Related publications

Discrepancies Between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2003

English

Plasma Concentrations of Boosted and Unboosted Atazanavir Are Predicted by 63396C>T SNP in the PXR Gene

Journal of the International AIDS Society

English

Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral Activities

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2001

English

Clinically Relevant Interpretation of Genotype and Relationship to Plasma Drug Concentrations for Resistance to Saquinavir-Ritonavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2004

English

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments

English

Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic in Vitro

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1998

English

Lysine and Threonine Plasma Concentrations in Ivorian Patients Living With Human Immunodeficiency Virus

Journal of AIDS and HIV Research

2017

English

Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease

English

Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Errol Babacan

Decrease of Atazanavir and Lopinavir Plasma Concentrations in a Boosted Double Human Immunodeficiency Virus Protease Inhibitor Salvage Regimen

Related publications

Discrepancies Between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients

Plasma Concentrations of Boosted and Unboosted Atazanavir Are Predicted by 63396C>T SNP in the PXR Gene

Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral Activities

Clinically Relevant Interpretation of Genotype and Relationship to Plasma Drug Concentrations for Resistance to Saquinavir-Ritonavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments

Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic in Vitro

Lysine and Threonine Plasma Concentrations in Ivorian Patients Living With Human Immunodeficiency Virus

Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease

Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance